JP2003511014A5 - - Google Patents

Download PDF

Info

Publication number
JP2003511014A5
JP2003511014A5 JP2001526577A JP2001526577A JP2003511014A5 JP 2003511014 A5 JP2003511014 A5 JP 2003511014A5 JP 2001526577 A JP2001526577 A JP 2001526577A JP 2001526577 A JP2001526577 A JP 2001526577A JP 2003511014 A5 JP2003511014 A5 JP 2003511014A5
Authority
JP
Japan
Prior art keywords
xaa
ala
arg
leu
unsure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001526577A
Other languages
English (en)
Japanese (ja)
Other versions
JP4723144B2 (ja
JP2003511014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/004716 external-priority patent/WO2001023427A1/en
Publication of JP2003511014A publication Critical patent/JP2003511014A/ja
Publication of JP2003511014A5 publication Critical patent/JP2003511014A5/ja
Application granted granted Critical
Publication of JP4723144B2 publication Critical patent/JP4723144B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001526577A 1999-09-29 2000-02-25 副甲状腺ホルモン(pth)のポリペプチド誘導体 Expired - Fee Related JP4723144B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15692799P 1999-09-29 1999-09-29
US60/156,927 1999-09-29
PCT/US2000/004716 WO2001023427A1 (en) 1999-09-29 2000-02-25 Polypeptide derivatives of parathyroid hormone (pth)

Publications (3)

Publication Number Publication Date
JP2003511014A JP2003511014A (ja) 2003-03-25
JP2003511014A5 true JP2003511014A5 (enExample) 2010-12-24
JP4723144B2 JP4723144B2 (ja) 2011-07-13

Family

ID=22561687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526577A Expired - Fee Related JP4723144B2 (ja) 1999-09-29 2000-02-25 副甲状腺ホルモン(pth)のポリペプチド誘導体

Country Status (6)

Country Link
EP (2) EP2030986A1 (enExample)
JP (1) JP4723144B2 (enExample)
AT (1) ATE412670T1 (enExample)
DE (1) DE60040678D1 (enExample)
ES (1) ES2316354T3 (enExample)
WO (1) WO2001023427A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE458054T1 (de) 1998-11-25 2010-03-15 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
AU4217299A (en) 1998-11-30 2000-06-19 General Hospital Corporation, The Pth1r and pth3r receptors, methods and uses thereof
US7169567B1 (en) 1998-12-31 2007-01-30 The General Hospital Corporation Screening assay utilizing the PTH receptor
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
JP4837888B2 (ja) 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン(pth)類似体
EP1592434A4 (en) * 2003-01-24 2009-07-01 Gen Hospital Corp CONFORMATION RESTRICTED PARATHORMON (PTH) ANALOGUE WITH LACTAM BRIDGES
JP5711966B2 (ja) 2007-08-01 2015-05-07 ザ ジェネラル ホスピタル コーポレイション Gタンパク質共役受容体および関連組成物を使用するスクリーニング方法
FR2940292B1 (fr) * 2008-12-23 2013-05-10 Isp Investments Inc Peptides derives d'hmg-coa reductase et composition cosmetique et/ou pharmaceutique les contenant
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2010128521A2 (en) * 2009-04-24 2010-11-11 Cadila Healthcare Limited Short-chain peptides as parathyroid hormone (pth) receptor agonist
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US4761406A (en) 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
WO1990009441A1 (en) 1989-02-01 1990-08-23 The General Hospital Corporation Herpes simplex virus type i expression vector
EP0945515A3 (en) 1989-11-06 2002-08-21 Cell Genesys, Inc. Production of proteins using homologous recombination
IT1238348B (it) 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
US5266490A (en) 1991-03-28 1993-11-30 Regeneron Pharmaceuticals, Inc. Mammalian expression vector
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5871486A (en) 1993-01-21 1999-02-16 Acumed, Inc. Variable pitch bone screw
ES2140359T1 (es) 1993-06-14 2000-03-01 Basf Ag Control preciso de expresion genetica en celulas eucarioticas mediante promotores que responden a la tetaciclina.
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5656465A (en) 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US5714353A (en) 1994-05-24 1998-02-03 Research Corporation Technologies, Inc. Safe vectors for gene therapy
US5836905A (en) 1994-06-20 1998-11-17 Lemelson; Jerome H. Apparatus and methods for gene therapy
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5917123A (en) 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
ATE458054T1 (de) * 1998-11-25 2010-03-15 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung

Similar Documents

Publication Publication Date Title
US20230167421A1 (en) Variants of a DNA Polymerase of the Polx Family
Rottier et al. Predicted membrane topology of the coronavirus protein E1
Moroder et al. Insulin—from its discovery to the industrial synthesis of modern insulin analogues
JP3054192B2 (ja) 副甲状腺ホルモンの製造のための組換えdna法
CA2246733C (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US8298789B2 (en) Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
JP2002530111A5 (enExample)
JP2003511014A5 (enExample)
JP2002510494A5 (enExample)
HU211856A9 (en) Peptides
CN108610398B (zh) 一段功能序列及在分泌蛋白表达中的应用
CN111132996A (zh) 用于重组蛋白表达的融合标签
RU2000103824A (ru) Адипоцит-специфические белковые гомологи
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
Einhauer et al. Expression and purification of homogenous proteins in Saccharomyces cerevisiae based on ubiquitin-FLAG fusion
CN1350584A (zh) 从新的融合蛋白制造重组胰岛素的方法
CN112105635A (zh) 用于重组蛋白的更高表达的前导序列
KR20210010365A (ko) 단백질 또는 폴리펩타이드 생산용 융합태그
CA2381439A1 (en) Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c
USRE37919E1 (en) Recombinant DNA method for production of parathyroid hormone
CN101389649A (zh) 多肽拮抗剂
CN1962695B (zh) 类胰高血素肽-1融合蛋白及其制备和用途
WO1986003779A1 (fr) Vecteur de secretion de polypeptides, micro-organismes transformes par ledit vecteur, et procede de preparation de polypeptides avec lesdits micro-organismes
Barlos et al. An optimized chemical synthesis of human relaxin‐2
EP1706494A2 (en) Method for production of recombinant growth hormone in form of hybrid protein